CN Bio raises $21 million to scale up organ-on-a-chip technology
CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions.
Archives for April 23, 2024
FDA approves Takeda’s self-administered Entyvio for Crohn’s disease
Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) version of Entyvio, its treatment for adults with moderate to severe Crohn’s disease (CD).
Could placenta-derived cells revolutionize age-related disease treatment?
Celularity, a biotech company specializing in placental-derived allogeneic cell therapies, will be showcasing data at the upcoming ASGCT Annual Meeting, showcasing the potential of their off-the-shelf natural killer (NK) cells to combat age-related...
Quotient Sciences new platform disrupts conventional drug development processes
At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.